Ahmet Özet

2.2k total citations
153 papers, 1.3k citations indexed

About

Ahmet Özet is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ahmet Özet has authored 153 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 47 papers in Pulmonary and Respiratory Medicine and 21 papers in Surgery. Recurrent topics in Ahmet Özet's work include Gastric Cancer Management and Outcomes (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Ahmet Özet is often cited by papers focused on Gastric Cancer Management and Outcomes (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Ahmet Özet collaborates with scholars based in Türkiye, United States and Serbia. Ahmet Özet's co-authors include Fikret Arpacı, Şeref Kömürcü, Bekir Öztürk, Selmin Ataergın, Nuriye Özdemir, Bülent Çetin, Mustafa Beneklı, İdris Yücel, Aytuğ Üner and Ozan Yazıcı and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Ahmet Özet

138 papers receiving 1.3k citations

Peers

Ahmet Özet
Paul Carter United Kingdom
Alfredo Tartarone Italy
Fikret Arpacı Türkiye
Rolf Richter Germany
Verena Katzke Germany
Wahyu Wulaningsih United Kingdom
Antonio Bossi Italy
Zhen Zeng China
Ryszard Gellert Poland
Paul Carter United Kingdom
Ahmet Özet
Citations per year, relative to Ahmet Özet Ahmet Özet (= 1×) peers Paul Carter

Countries citing papers authored by Ahmet Özet

Since Specialization
Citations

This map shows the geographic impact of Ahmet Özet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmet Özet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmet Özet more than expected).

Fields of papers citing papers by Ahmet Özet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmet Özet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmet Özet. The network helps show where Ahmet Özet may publish in the future.

Co-authorship network of co-authors of Ahmet Özet

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmet Özet. A scholar is included among the top collaborators of Ahmet Özet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmet Özet. Ahmet Özet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Özdemir, Nuriye, et al.. (2025). Effect of a ChatGPT-based digital counseling intervention on anxiety and depression in patients with cancer: A prospective, randomized trial. European Journal of Cancer. 221. 115408–115408. 6 indexed citations
3.
4.
Yazıcı, Ozan, et al.. (2024). The Prognostic Value of the Preoperative Geriatric Nutritional Risk Index in Elderly Colon Cancer Patients Underwent Curative Resection. Acta Oncologica Turcica. 57(1). 14–21. 1 indexed citations
5.
Üner, Aytuğ, et al.. (2024). Carcinoma erysipeloides, a case-report and review of the sixty-nine cases in the literature. The American Journal of the Medical Sciences. 369(4). 485–490.
6.
Türkmen, Seval, et al.. (2024). Impact of Serum GDF-15 and IL-6 on Immunotherapy Response in Cancer: A Prospective Study. Cancers. 16(24). 4146–4146. 2 indexed citations
7.
Akyürek, Nalân, Gökhan Uçar, Doğan Uncu, et al.. (2024). Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancer Investigation. 42(2). 141–154.
8.
Yazıcı, Ozan, et al.. (2023). Earthquake disaster impact on health care of cancer patients: Single center experience. SHILAP Revista de lepidopterología. 5(4). 234–239. 3 indexed citations
9.
Özet, Ahmet, et al.. (2023). Retrospective Analysis of Real-Life Data Evaluating the Optimal Time Between Gastrectomy and Adjuvant Chemotherapy in Resected Gastric Cancer. Journal of Gastrointestinal Cancer. 54(4). 1268–1275. 2 indexed citations
10.
Özet, Ahmet, Faysal Dane, Nuri Faruk Aykan, et al.. (2022). Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey. Future Oncology. 18(29). 3267–3276. 2 indexed citations
11.
Özet, Ahmet, et al.. (2022). Evaluation of scientific reliability and quality of YouTube videos on cancer and nutrition. Nutrition. 108. 111933–111933. 10 indexed citations
12.
Çengiz, Bülent, et al.. (2021). A Case of Myasthenia Gravis with Two Primary Tumors: Paraneoplastic or Incidental?. Journal of Gastrointestinal Cancer. 53(3). 837–840. 1 indexed citations
13.
Yalçın, Şuayib, et al.. (2020). COVID-19 Pandemisi Döneminde Tıbbi Onkolojide Kanserli Hastaya Yaklaşım İlkeleri. 1(8). 45–49. 1 indexed citations
14.
Bachet, Jean‐Baptiste, Lucjan Wyrwicz, Timothy Price, et al.. (2020). Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study. ESMO Open. 5(3). e000698–e000698. 31 indexed citations
15.
Tural, Deniz, et al.. (2019). Receptor discordances after neoadjuvant chemotherapy and their effects on survival.. PubMed. 24(1). 20–25. 16 indexed citations
16.
Kanat, Özkan, Ahmet Özet, Selmin Ataergın, et al.. (2010). Modified Outpatient Dexamethazone, Cytarabine and Cisplatin Regimen May Lead to High Response Rates and Low Toxicity in Lymphoma. Medical Principles and Practice. 19(5). 344–347. 11 indexed citations
17.
Bağçıvan, Gülcan, et al.. (2009). Analysis of Patient-Related Barriers in Cancer Pain Management in Turkish Patients. Journal of Pain and Symptom Management. 38(5). 727–737. 34 indexed citations
18.
Ataergın, Selmin, Fikret Arpacı, Murat Demiriz, & Ahmet Özet. (2008). Transient Efficacy of Double High-Dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation, Immunoglobulin, Thalidomide, and Bortezomib in the Treatment of Scleromyxedema. American Journal of Clinical Dermatology. 9(4). 271–273. 18 indexed citations
19.
Özet, Ahmet, Bülent Kurt, Şeref Kömürcü, et al.. (2007). Impact of c-erb2 status on survival after high dose chemotherapy in high-risk breast cancer patients.. PubMed. 28(9). 1374–9. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Carter Breakdown of academic impact, for papers by Alfredo Tartarone Breakdown of academic impact, for papers by Fikret Arpacı Breakdown of academic impact, for papers by Rolf Richter Breakdown of academic impact, for papers by Verena Katzke Breakdown of academic impact, for papers by Wahyu Wulaningsih Breakdown of academic impact, for papers by Antonio Bossi Breakdown of academic impact, for papers by Zhen Zeng Breakdown of academic impact, for papers by Ryszard Gellert
Rankless by CCL
2026